Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

• Status: Recruiting
• Trial end date: 2022-01-31
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET and Ga-68-DOTATOC PET in patients with meningioma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Weill Medical College of Cornell University
• Collaborator: Cornell University
• Treatments: Edotreotide; Octreotide

Criteria

Inclusion Criteria:

• Adult patients with clinically suspected meningioma

• Patients planned for surgery - undergoing preoperative workup

• No contraindications to either radiotracer

Exclusion Criteria:

• Age less than 18 years

• Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.